Li, X., Zhang, S., Guo, G., Han, J
They can help reduce inflammation but it is not verified that they can treat certain Autoimmune Diseases, and more research has to be conducted.
Acute kidney injury has been reported in patients experiencing severe vomiting or diarrhea leading to dehydration
Nausea incidence with GLP-1 therapies varies by agent, dose, and population, but current research indicates that roughly one in five to one in two users experience some nausea, most often during the first weeks of therapy
Get Educated Welcome to Get Educated with Emergeyour go-to for GLP-1 and wellness